Roche sticks to 2010 goals despite earnings miss (Reuters, 22 July 2010)

Increases In Leptin May Promote Colorectal Cancer (Medical News Today, 21 July 2010)

UK's NICE rejects Roche's Avastin in breast cancer (Reuters, 8 July 2010)

08 Jul 2010

The National Institute for Health and Clinical Excellence has released draft guidelines to recommend against NHS provision of Roche's Avastin (generic name bevacizumab) for advanced breast cancer, stating that clinical trials of the drug produced "uncertain evidence".

Update: US panel rejects Roche's Avastin for breast cancer (Reuters, 20 July 2010).

Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story

Top stories

Call for nominations for Awards Committee Chair
30 Oct 2024

James M Tanner Award - 2025 nominations open
30 Oct 2024

Would you like to host the BSPED annual meeting?
21 Oct 2024

Most read